Renowned protease expert confirmed as CSO of ProAxsis
Date : January 20, 2016
ProAxsis is pleased to announce that Professor Brian Walker, a vastly experienced expert in the design and synthesis of Protease-Tags™ for the identification and validation of protease targets of biomedical and pharmaceutical importance, has been confirmed in the role of Chief Scientific Officer, effective immediately. Professor Walker, who is a co-founder of ProAxsis and had previously held the role of CSO on a consultancy basis, said: “I am thrilled to be part of a company with such exciting potential to make a real difference in diseases such as Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.”
Dr David Ribeiro, CEO of ProAxsis, added: “Professor Walker is widely recognised as one of the foremost experts on proteases in the World, so I am delighted that he has committed himself to ProAxsis. 2016 will be a transformational year for the company, with a number of key appointments expected to be made, and this is an important first step.”
ProAxsis is part of the NetScientific group and is one of the group’s core portfolio companies. The company is also supported by QUBIS, the commercialisation arm of Queens University.